• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保留生育功能手术治疗原发性卵巢黏液性癌的安全性

Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary.

作者信息

Lee Jung-Yun, Jo Yu Ri, Kim Tae Hun, Kim Hee Seung, Kim Min A, Kim Jae Weon, Park Noh Hyun, Song Yong-Sang

机构信息

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Cancer Res Treat. 2015 Apr;47(2):290-7. doi: 10.4143/crt.2014.004. Epub 2014 Aug 29.

DOI:10.4143/crt.2014.004
PMID:25287480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4398117/
Abstract

PURPOSE

The aim of this study is to evaluate the safety of fertility-sparing surgery as the treatment for patients with primary mucinous epithelial ovarian cancer.

MATERIALS AND METHODS

A retrospective study of patients with mucinous ovarian cancer between 1991 and 2010 was performed. The demographics and survival outcomes were compared between patients who underwent fertility-sparing surgery and those who underwent radical surgery.

RESULTS

A total of 110 patients underwent primary surgery. At the time of surgery, tumors appeared to be grossly confined to the ovaries in 90 patients, and evidence of metastasis was definite in 20 patients. Of the 90 patients with tumors that appeared to be grossly confined to the ovaries at surgical exploration, 35 (38.9%) underwent fertility-sparing surgery. The Kaplan- Meier curve and the log rank test showed no difference in either recurrence-free survival (p=0.792) or disease-specific survival (p=0.706) between the two groups. Furthermore, there was no significant difference in recurrence-free survival (p=0.126) or disease-specific survival (p=0.377) between the two groups, even when the analysis was limited to women below the age of 40. In a multivariate Cox model, fertility-sparing surgery had no effect on either recurrence-free survival (recurrence hazard ratio [HR], 1.20; 95% confidence interval [CI], 0.25 to 5.71) or disease-specific survival (death HR, 0.88; 95% CI, 0.17 to 4.60).

CONCLUSION

Fertility-sparing surgery in primary mucinous cancer grossly confined to the ovaries may be a safe option and one not associated with an increase in recurrence or mortality.

摘要

目的

本研究旨在评估保留生育功能手术治疗原发性黏液性上皮性卵巢癌患者的安全性。

材料与方法

对1991年至2010年间黏液性卵巢癌患者进行回顾性研究。比较接受保留生育功能手术的患者与接受根治性手术的患者的人口统计学和生存结局。

结果

共有110例患者接受了初次手术。手术时,90例患者的肿瘤肉眼可见局限于卵巢,20例患者有明确的转移证据。在手术探查时肿瘤肉眼可见局限于卵巢的90例患者中,35例(38.9%)接受了保留生育功能手术。Kaplan-Meier曲线和对数秩检验显示,两组之间的无复发生存率(p = 0.792)或疾病特异性生存率(p = 0.706)均无差异。此外,即使将分析仅限于40岁以下的女性,两组之间的无复发生存率(p = 0.126)或疾病特异性生存率(p = 0.377)也无显著差异。在多变量Cox模型中,保留生育功能手术对无复发生存率(复发风险比[HR],1.20;95%置信区间[CI],0.25至5.71)或疾病特异性生存率(死亡HR,0.88;95%CI,0.17至4.60)均无影响。

结论

对于肉眼可见局限于卵巢的原发性黏液性癌,保留生育功能手术可能是一种安全的选择,且不会增加复发或死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/4398117/c1f359ba8bd0/crt-2014-004f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/4398117/227e026fa931/crt-2014-004f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/4398117/c1f359ba8bd0/crt-2014-004f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/4398117/227e026fa931/crt-2014-004f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/4398117/c1f359ba8bd0/crt-2014-004f2.jpg

相似文献

1
Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary.保留生育功能手术治疗原发性卵巢黏液性癌的安全性
Cancer Res Treat. 2015 Apr;47(2):290-7. doi: 10.4143/crt.2014.004. Epub 2014 Aug 29.
2
Safety of fertility sparing management in invasive mucinous ovarian carcinoma.侵袭性黏液性卵巢癌中保留生育力管理的安全性。
Gynecol Oncol. 2023 Jul;174:129-132. doi: 10.1016/j.ygyno.2023.05.003. Epub 2023 May 12.
3
All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.I期上皮性卵巢癌保留生育功能手术后的全因死亡率
Obstet Gynecol. 2017 Jul;130(1):71-79. doi: 10.1097/AOG.0000000000002102.
4
Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature.国际妇产科联盟(FIGO)I期透明细胞卵巢癌患者的保留生育功能手术:一项数据库分析及文献系统综述
Int J Gynecol Cancer. 2020 Sep;30(9):1372-1377. doi: 10.1136/ijgc-2020-001716. Epub 2020 Aug 25.
5
Fertility sparing surgery in early stage epithelial ovarian cancer.早期上皮性卵巢癌的保留生育功能手术
J Gynecol Oncol. 2014 Oct;25(4):320-7. doi: 10.3802/jgo.2014.25.4.320. Epub 2014 Jun 18.
6
Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.Ⅰ期单纯未成熟型卵巢畸胎瘤患者行保留生育功能手术后行分期手术和辅助化疗的作用。
Int J Gynecol Cancer. 2020 May;30(5):664-669. doi: 10.1136/ijgc-2019-001116. Epub 2020 Mar 15.
7
Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.保留生育功能手术治疗膨胀性浸润性黏液性卵巢癌的疗效。
Oncologist. 2018 Mar;23(3):324-327. doi: 10.1634/theoncologist.2017-0310. Epub 2017 Dec 14.
8
The effect of chemotherapy in patients with stage I mucinous ovarian cancer undergoing fertility-sparing surgery.I期黏液性卵巢癌患者接受保留生育功能手术后化疗的效果。
Front Oncol. 2022 Nov 8;12:1028842. doi: 10.3389/fonc.2022.1028842. eCollection 2022.
9
Long-term survival after fertility-sparing surgery for epithelial ovarian cancer.上皮性卵巢癌保留生育功能手术后的长期生存情况。
Int J Gynecol Cancer. 2009 Oct;19(7):1199-204. doi: 10.1111/IGC.0b013e31819d82c3.
10
Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer.
Int J Gynecol Cancer. 2022 Oct 3;32(10):1276-1282. doi: 10.1136/ijgc-2022-003560.

引用本文的文献

1
Fertility-sparing surgery upon reproductive and oncologic results in ovarian cancer patients stage I (FIGO): a systematic review.I期(国际妇产科联盟)卵巢癌患者保留生育功能手术对生殖及肿瘤学结局的影响:一项系统评价
Arch Gynecol Obstet. 2025 May 23. doi: 10.1007/s00404-025-08062-y.
2
Fertility-Sparing Surgery in Infiltrative Mucinous Carcinoma of the Ovary.卵巢浸润性黏液性癌的保留生育功能手术
Case Rep Oncol. 2023 Nov 29;16(1):1494-1499. doi: 10.1159/000534737. eCollection 2023 Jan-Dec.
3
Rare Epithelial Ovarian Cancers: Low Grade Serous and Mucinous Carcinomas.

本文引用的文献

1
Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study.高级别黏液性上皮性卵巢癌与浆液性上皮性卵巢癌的化疗敏感性和生存结局比较:一项匹配的病例对照研究。
J Gynecol Oncol. 2013 Apr;24(2):160-6. doi: 10.3802/jgo.2013.24.2.160. Epub 2013 Apr 5.
2
Conservative fertility-sparing surgical treatment of invasive epithelial ovarian cancer: when is it acceptable?侵袭性上皮性卵巢癌的保守性保留生育功能手术治疗:何时可接受?
Isr Med Assoc J. 2013 Feb;15(2):116-20.
3
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series.
罕见的上皮性卵巢癌:低级别浆液性和黏液性癌。
Cold Spring Harb Perspect Med. 2023 Sep 1;13(9):a038190. doi: 10.1101/cshperspect.a038190.
4
Evaluation of Outcomes of Mucinous Ovarian Cancer Treated at a Tertiary Care Cancer Hospital in Pakistan.巴基斯坦一家三级癌症专科医院治疗的黏液性卵巢癌的疗效评估。
South Asian J Cancer. 2022 Aug 22;12(1):81-86. doi: 10.1055/s-0042-1755582. eCollection 2023 Jan.
5
Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer.黏液性卵巢癌预后和预测标志物的最新进展
Cancers (Basel). 2023 Feb 12;15(4):1172. doi: 10.3390/cancers15041172.
6
Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma.I期黏液性卵巢癌保留生育功能手术后的肿瘤学及生殖结局
Front Oncol. 2022 Jul 4;12:856818. doi: 10.3389/fonc.2022.856818. eCollection 2022.
7
Options for the Treatment of Mucinous Ovarian Carcinoma.黏液性卵巢癌的治疗选择
Curr Treat Options Oncol. 2021 Nov 13;22(12):114. doi: 10.1007/s11864-021-00904-6.
8
Fertility-Sparing Surgery for Ovarian Cancer.卵巢癌保留生育功能手术
J Clin Med. 2021 Sep 18;10(18):4235. doi: 10.3390/jcm10184235.
9
Fertility-Sparing Surgery in Gynecologic Cancer: A Systematic Review.妇科癌症保留生育功能手术:一项系统评价
Cancers (Basel). 2021 Feb 28;13(5):1008. doi: 10.3390/cancers13051008.
10
Conservative management of stage IIB ovarian carcinoma with favorable oncology and fertility outcomes.IIB期卵巢癌的保守治疗,具有良好的肿瘤学和生育结局。
Gynecol Oncol Rep. 2021 Jan 7;35:100691. doi: 10.1016/j.gore.2020.100691. eCollection 2021 Feb.
早期上皮性卵巢癌的保守治疗:一项大型回顾性系列研究的结果。
Ann Oncol. 2013 Jan;24(1):138-44. doi: 10.1093/annonc/mds241. Epub 2012 Sep 3.
4
Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery.年轻女性接受保留生育功能的卵巢癌手术与接受根治性手术的长期生存比较。
Br J Cancer. 2011 Oct 25;105(9):1288-94. doi: 10.1038/bjc.2011.394. Epub 2011 Oct 4.
5
Fertility-sparing surgery in young women with mucinous adenocarcinoma of the ovary.年轻女性卵巢黏液性腺癌的保留生育功能手术。
Gynecol Oncol. 2011 Aug;122(2):334-8. doi: 10.1016/j.ygyno.2011.04.016. Epub 2011 May 14.
6
Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary.原发性卵巢黏液性癌的淋巴结转移率。
Obstet Gynecol. 2010 Aug;116(2 Pt 1):269-273. doi: 10.1097/AOG.0b013e3181e7961d.
7
Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection.保留生育功能手术治疗 I 期上皮性卵巢癌的结局:患者选择的建议。
J Clin Oncol. 2010 Apr 1;28(10):1727-32. doi: 10.1200/JCO.2009.24.8617. Epub 2010 Mar 1.
8
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.上皮性卵巢癌的起源和发病机制:一种提出的统一理论。
Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
9
Fertility preservation in patients with early epithelial ovarian cancer.早期上皮性卵巢癌患者的生育力保存。
J Gynecol Oncol. 2009 Mar;20(1):44-7. doi: 10.3802/jgo.2009.20.1.44. Epub 2009 Mar 31.
10
Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.侵袭性上皮性卵巢癌保留生育功能手术的结局:肿瘤学安全性和生殖结局。
Gynecol Oncol. 2008 Sep;110(3):345-53. doi: 10.1016/j.ygyno.2008.04.040. Epub 2008 Jun 30.